Two patients who developed localised radiation retinopathy many years after brachytherapy for retinoblastoma are described. In both patients extracapsular cataract extraction and YAG laser capsulotomy were followed by preretinal and vitreous haemorrhage and in one patient there was deterioration of existing radiation retinopathy with macular oedema. Premacular and vitreous haemorrhage occurred from focal, preretinal neovascular membranes which appeared to originate from residual choroidal vascular radicals. Laser photocoagulation was successful in ablating preretinal neovascular membranes and limiting the extent of macular oedema from incompetent retinal capillaries adjacent to the atrophic macular scars. (BrJ3 Ophthalmol 1993; 77: 95-99) 
Brachytherapy is an effective and firstline therapy for selected retinoblastomas, and where the macula and optic nerve are uninvolved the visual prognosis is typically good. "A Most brachytherapeutic schedules aim to deliver about 40 Gy of radiation to the tumour apex and 100-160 Gy to the scleral base.-5 The retinal vessels are judged to be at risk when the total dose of radiation exceeds 30 Gy, although retinopathic changes are often slow to emerge and may not be obvious on routine clinical examination. All patients receiving brachytherapy for retinoblastoma develop retinal vascular changes at or adjacent to the tumour site, although the degree and extent of retinopathy are highly variable and visual functions may only be affected significantly if the macula is implicated in the disease process.2"
A proportion of patients receiving brachytherapy for retinoblastomas, particularly those receiving multiple treatments for equatorial or peripheral tumours, develop lens opacities, although the cataract is typically slow to develop and may not present for years after the initial tumour therapy.'-366Where retinoblastomas are treated by combined brachytherapy and teletherapy, there is a higher incidence and early appearance of cataract and increased likelihood of significant radiation retinopathy. ' The literature records instances of successful cataract extraction and visual recovery in patients who received teletherapy for intraocular and extraocular tumours,7-"0 and brachytherapy for retinoblastomas and choroidal melanomas," 12 This female patient was diagnosed as suffering from bilateral retinoblastomas in 1952, at the age of 2 years and 4 months. The right eye was enucleated (22 February 1952) , and two radon seeds secured to the left inferior sclera (13 March 1952) (Fig IA) . There were striking drusen of the optic disc. Microvascular abnormalities extended from the temporal margin of the scar to involve the inferior macula and there was pronounced exudation and fluid accumulation at and beyond the macular region ( Fig IB) . The exudates were located deep within the retina. Subtle capillary defects were also present superior and nasal to the chorioretinal scar and associated with intraretinal exudation.
Angiography confirmed the presence of choroidoretinal communications and neovascular membranes arising from residual choroidal vessels at the inferior chorioretinal scar. At the temporal margin of the scar there were dilated capillaries, intraretinal microvascular abnormalities, and evidence of inner retinal ischaemia at the inferior macula. Some of the major retinal vessels adjacent to the treatment scar were severely constricted, sheathed, or occluded ( Fig  2) . The abnormal vessels leaked and stained with dye in the late angiographic frames. Capillary abnormalities and drusen at the optic disc fluoresced brightly in late angiography.
Argon laser photocoagulation was carried out to the region of incompetent vessels which juxtaposed the radiation scar and directly to the area of the neovascular membranes on three occasions. Haemorrhage, fluid, and exudates gradually absorbed with improvement of visual acuity. At final review (5 March 1992) there was almost complete absorption of haemorrhage and exudates, and acuity improved to 6/18 part ( Fig  3) . Reading vision was N/5 with +6-00 DS at 9 inches. A small, isolated, residual preretinal haemorrhage remained within the body of the scar, but this was not associated with any neovascular membrane or abnormal vascular complexes. Fluorescein angiography confirmed that the macular and perifoveolar microvasculatures were intact and competent and that the focal retinopathy temporal to the radiation scar had atrophied in part following laser photocoagulation (Fig 4) . All choroidoretinovitreal neovascular membranes had resolved, although residual choriocapillaris units within the chorioretinal scar fluoresced brightly in the later phase angiograms. The posterior vitreous face was detached. CASE 2 This male patient was diagnosed as suffering from bilateral retinoblastomas in 1952. His left eye was enucleated at age 18 months, and discrete tumours, superior to the right macula, were treated with radon seeds. The tumours atrophied and were replaced by full thickness chorioretinal scars, superior to the main superotemporal vascular arcades and extending to the ora serrata. Acuity remained 6/5 unaided in the right eye.
In 1970 the patient developed sectorial posterior subcapsular lens opacities which gave symptoms of glare but did not substantially affect acuity. Symptoms responded to drops of pilocarpine 0 5% three times daily. Examination in 1977 revealed a focus of new vessels at the centre of the atrophic scar but identified no evidence of tumour recurrence. The lens opacities slowly progressed and by 11 June 1990 acuity was 6/36 (N 18). Examination of the fundus at this time only revealed an atrophic chorioretinal scar with no evidence of radiation retinopathy or residual new vessels.
Right extracapsular cataract extraction with intraocular lens implantation was carried out on 13 June 1990. There was dense opacification and fibrosis of the posterior lens capsule which was resistant in part to intraoperative debridement. Two weeks postoperatively a large preretinal haemorrhage was observed at the radiation scar, together with an area of exudation. Opacification 13 14 In general, radiation retinopathy subsequent to brachytherapy extends only a short distance beyond the margin ofthe atrophic radiation scar, and where the lesions are extramacular central visual functions typically remain good.3'314 In contrast to retinopathy associated with teletherapy, the retinal vascular lesions induced by radioactive plaque therapy show little evidence ofprogression and the discrete areas ofischaemic retina are rarely associated with preretinal neovascularisation.3'3'4
The two patients described in this report were typical in that they displayed stable, discrete, atrophic chorioretinal scars at the site of radon seed therapy and demonstrated no significant or identifiable vasculopathy in the adjoining retina. In each instance the chorioretinal scars were extramacular and good central visual functions were maintained until lens opacities developed. Cataracts were identified within a few years of therapy; however, progression was slow,6 and it was not until 35 years or so post-therapy that deterioration of vision dictated cataract extraction.-Patients developing cataract following brachytherapy for choroidal melanomas do so more rapidly, probably reflecting higher doses of radiation to the eye. 15 16 Cataract surgery in both patients was associated with the development of preretinal or vitreous haemorrhage at the radiation scar from choroidoretinal vascular abnormalities. In patient 2 there was also a profuse outpouring of opalescent fluid in the region of the scar, which was probably a fibrin-rich exudate from incompetent vessels at or adjacent to the irradiated retina and choroid. This elevated opaque lesion initially raised the possibility of local recurrence of tumour,'7 but it gradually disappeared with time and was not linked to the original neoplasm.
Some of the vascular abnormalities detected within the atrophic radiation scar had the features of choroidoretinal communications or choroidoretinovitreal neovascular membranes. Both vascular anomalies filled rapidly with dye from the choroidal circulation; however, the choroidoretinal communications remained competent, whereas the neovascular membranes profusely leaked dye. The choroidovitreal neovascular complexes were discrete and, although of varying calibre, had an angiomatous-like quality to their vitreoretinal component. These neovascular membranes expanded slowly and ramified at the level of the internal limiting membrane, appearing to gain attachment to the posterior vitreous face. Detachment of the posterior vitreous face following cataract surgery and YAG laser capsulotomy'8 19 is the most likely cause of their disruption and subsequent preretinal and vitreous haemorrhage. Haemorrhage into the vitreous body in patient 2 cleared relatively rapidly; however, preretinal haemorrhage at the chorioretinal scars in both patients remained unchanged for many months, reflecting the attenuated circulation and limited phagocytic activity in this region.
Egbert et al20 described vitreous haemorrhage in some of their patients receiving teletherapy for retinoblastomas. They believed the haemorrhage arose from unsupported tumour vessels in 'shrinking tumour'; however, these haemorrhages were noted soon after radiation retinopathy and probably have different origins from t14ose described in this report.
Choroidoretinal vascular communications occur commonly within chorioretinal scars and are most often observed in longstanding disciform scars associated with age-related macular degeneration.2' They are a component of the organisational process, but remain competent and do not adversely affect the neighbouring retina or require treatment. Choroidoretinovitreal neovascular complexes also occur at sites of chorioretinal atrophy and may follow intense photocoagulation of attenuated ischaemic retina 
